Trials / Terminated
TerminatedNCT05091060
Effect of the Erchonia® HLS™ for the Relief of Tinnitus Symptoms
Erchonia and InnerScope, Pilot Evaluation of the Effect of the Erchonia® HLS™ for the Relief of Tinnitus Symptoms
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Erchonia Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to see if applying red low-level laser light can help to reduce tinnitus symptoms
Detailed description
The purpose of this pilot study is to determine the effectiveness of the Erchonia® HLS™, manufactured by Erchonia Corporation (the Company), in providing temporary relief of tinnitus symptoms in adults 18 years and older.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Erchonia HLS | 56 procedure administrations with the Erchonia® HLS™ administered by the subject at home: daily procedure administrations for 8 weeks. |
Timeline
- Start date
- 2021-06-10
- Primary completion
- 2022-03-14
- Completion
- 2022-03-14
- First posted
- 2021-10-25
- Last updated
- 2023-08-30
- Results posted
- 2023-08-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05091060. Inclusion in this directory is not an endorsement.